(1)
Peng, L. .; He, J. .; Zheng, Y. .; Zeng, Q. Effects of Monoclonal Antibody Daratumumab Combined With Ixazomib-Based Treatment Regimen on Survival of Patients With Relapsed Refractory Multiple Myeloma. Vojnosanit Pregl 2025, 82 (04). https://doi.org/10.2298/VSP231207016P.